Enterostatin efflux in cat intestinal lymph: relation to lymph flow, hyaluronan, and fat absorption

M I Townsley1, C Erlanson-Albertsson, A Ohlsson

  • 1Department of Physiology, University of South Alabama, Mobile 36688, USA.

Insights

Enterostatin, a peptide from pancreatic procolipase, increases in intestinal lymph after fat absorption. However, this study found enterostatin does not alter intestinal hyaluronan turnover, despite its elevated lymph levels.

Area of Science:

  • Gastroenterology
  • Physiology
  • Molecular Biology

Background:

  • Enterostatin is the activation peptide of pancreatic procolipase.
  • Hyaluronan turnover is a key process in intestinal function.
  • The role of enterostatin in intestinal hyaluronan metabolism via lymph was previously unclear.

Purpose of the Study:

  • To investigate whether enterostatin modulates intestinal hyaluronan turnover through lymphatic transport.
  • To determine the relationship between fat absorption, enterostatin levels in lymph, and hyaluronan efflux.

Main Methods:

  • Surgical isolation of feline ileal segments with cannulated lymphatic drainage.
  • In situ autoperfusion of isolated ileal segments.
  • Measurement of immunoreactive enterostatin concentrations in lymph and plasma under various conditions (baseline, fat absorption, high lymph flow).
  • Intestinal lumen perfusion with oleic acid and taurocholate.
  • Introduction of enterostatin into the ileum via intra-arterial bolus or lumen perfusion.

Main Results:

  • Enterostatin concentration in lymph significantly increased after cream feeding and oleic acid perfusion, with lymph/plasma ratios rising from baseline.
  • At high lymph flows, enterostatin concentrations decreased, altering the lymph/plasma ratio.
  • Despite increased enterostatin levels in lymph post-fat absorption, direct administration of enterostatin into the ileum did not alter hyaluronan efflux into the lymph.

Conclusions:

  • Enterostatin concentration in intestinal lymph increases following fat absorption, even when pancreatic secretions are blocked.
  • Enterostatin does not appear to modify intestinal hyaluronan turnover or its efflux into the lymph.
  • The observed correlation between hyaluronan efflux and fat absorption is likely independent of enterostatin's direct action on hyaluronan metabolism.